A versatile supramolecular nanoadjuvant that activates NF-κB for cancer immunotherapy

Although powerful adjuvants hold promise of vaccines for cancer immunotherapy, cumbersome preparation processes, elusive mechanisms and failure to induce T cell responses have largely limited their clinical translation. Due to their ease of synthesis, good biocompatibility and designable bioactivity...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yan, Wang, Youzhi, Yang, Quanli, Liu, Zhijia, Xiao, Zhiqiang, Le, Zhicheng, Yang, Zhimou, Yang, Chengbiao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567969/
https://www.ncbi.nlm.nih.gov/pubmed/31244959
http://dx.doi.org/10.7150/thno.34031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567969/
https://www.ncbi.nlm.nih.gov/pubmed/31244959
http://dx.doi.org/10.7150/thno.34031

Ejemplares similares